HBsAg decline after interrupting nucleos(t)ide analogue therapy in HVeAg-negative chronic hepatitis B

Authors :: Eva Herrmann
M. Cornberg
H. Wedemeyer
Benjamin Maasoumy
C. Mix
F. Rinker
Kerstin Port
Natalie Filmann
Katja Deterding
Christine S. Falk
C Höner zu Siederdissen
Michael P. Manns
Arm Kraft
Source :: Journal of Clinical Virology. 69:233
Publication Year :: 2015
Publisher :: Elsevier BV, 2015.

Subjects :: HBsAg
Infectious Diseases
Chronic hepatitis
business.industry
Virology
Medicine
business

Full Text Access

Tools